Akums Drugs and Pharmaceuticals IPO — Listing Performance
Akums Drugs and Pharmaceuticals IPO facts & figures
| Issue category | Mainboard |
|---|---|
| Issue open date | 30 Jul 2024 |
| Listing date | 6 Aug 2024 |
| Issue price | ₹679 |
| Listing-day close | ₹796.25 (17.27%) |
| Recent market price | ₹776.35 (14.34% vs issue) |
| 52-week range | ₹414.05 – ₹780.55 |
| Identifiers | NSE: AKUMS · ISIN: INE09XN01023 |
How the listing went
Akums Drugs and Pharmaceuticals saw a healthy listing pop, closing day one 17.27% above the issue price.
Akums Drugs and Pharmaceuticals against every other debut on record
- Rank in 2024: 169 of 262 NSE debuts, on a 17.27% first-day close.
- 45th percentile of 86 mainboard debuts in 2024 (median 21.06%).
- 23rd of 27 debuts in August 2024.
- Opened 6.77% above issue, then added 10.5 points to the close.
- Day-one range ₹725 to ₹797.50: a 10.68% swing on the issue price.
- Last close ₹776.35 (11 Sep 2026): 14.34% above issue, against 17.27% on day one.
- 99% up its 52-week range of ₹414.05 to ₹780.55.
- Priced at the top of the ₹646 to ₹679 band.
- Listed 5 calendar days after close.
- All 508 mainboard debuts on record: median 12.01%, 72% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources